| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2019/02/19 | 21 : 12 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2019/02/19 | 21 : 06 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2019/02/19 | 21 : 00 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2019/02/14 | 17 : 02 | Dow Jones News | Generics Maker Teva Turns Toward Biotech -- WSJ | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2019/02/14 | 01 : 51 | Dow Jones News | Teva Shares Fall Sharply on 2018 Misses, Light 2019 Targets | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2019/02/13 | 22 : 54 | Dow Jones News | King of Generics Pushes Into Biotech Drugs | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2019/02/13 | 21 : 00 | Business Wire | Teva Reports Fourth Quarter and Full Year 2018 Financial Results | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2019/02/07 | 01 : 13 | Business Wire | Teva Announces U.S. Launch of a Generic Version of Sabril® (Vigabatrin) | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2019/02/06 | 08 : 57 | Business Wire | Teva Announces Launch of ALYQ™ (Tadalafil Tablets USP), a Generic Version of ADCIRCA® in the United States | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2019/02/02 | 04 : 33 | Dow Jones News | Amgen, Eli Lilly Migraine Drugs to Be Covered by UnitedHealth Unit -Reuters | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2019/02/01 | 20 : 50 | Business Wire | Teva Receives Positive Committee for Medicinal Products for Human Use (CHMP) Opinion for AJOVY® (fremanezumab) for the Proph... | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2019/01/17 | 03 : 50 | Dow Jones News | FDA Approves Teva's Generic Version of Epilepsy Drug | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2019/01/15 | 06 : 00 | Business Wire | Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2018 Financial Results at 8 a.m. ET on February 13, 2019 | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2019/01/07 | 02 : 45 | Business Wire | Teva to Present at the 37th Annual J.P. Morgan Healthcare Conference | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2019/01/03 | 10 : 28 | Business Wire | Teva and Amgen Resolve Ongoing Dispute Over Teva’s Generic Cinacalet HCl Product | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2018/12/28 | 02 : 05 | Business Wire | Teva Announces US Launch of a Generic Version of Elidel® (Pimecrolimus) Cream, 1% | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2018/12/23 | 01 : 06 | Business Wire | ADDING MULTIMEDIA Teva Announces FDA Approval of First & Only Digital Inhaler with Built-In Sensors – ProAir® Digihaler™... | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2018/12/22 | 06 : 39 | Dow Jones News | FDA Approves Teva's Digital Asthma Inhaler With Built-In Sensors | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2018/12/22 | 05 : 19 | Business Wire | Teva Announces FDA Approval of First & Only Digital Inhaler with Built-In Sensors – ProAir® Digihaler™ (albuterol sulfat... | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2018/12/19 | 06 : 09 | Dow Jones News | FTC Approves Teva Petition to Give Pfizer More Time to Sell Drug | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2018/12/17 | 22 : 00 | Business Wire | Teva Announces Positive Topline Phase IIIb Results with Fremanezumab in Adults with Migraine Who Did Not Respond to Multiple ... | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2018/12/15 | 08 : 31 | Business Wire | Celltrion & Teva Announce FDA Approval of HERZUMA® (trastuzumab-pkrb), a Biosimilar to HERCEPTIN®, for the Treatment of HER... | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2018/12/15 | 07 : 57 | Dow Jones News | FDA Approves Herceptin Biosimilar Herzuma | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2018/12/13 | 00 : 33 | Dow Jones News | FDA Issues Warning Letter to Zhejiang Huahai in Valsartan Recall | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2018/11/29 | 05 : 38 | Business Wire | Celltrion & Teva Announce FDA Approval of TRUXIMA® (rituximab-abbs), a Biosimilar to RITUXAN®, for Three Non-Hodgkin’s Ly... | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2018/11/28 | 02 : 08 | Dow Jones News | Teva Releases Generic EpiPen in Limited Doses in the U.S. -- Update | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2018/11/28 | 02 : 04 | Dow Jones News | Teva Releases Generic EpiPen in Limited Doses in the U.S. -- Update | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2018/11/28 | 01 : 02 | Dow Jones News | Teva Releases Limited Doses of Generic Version of EpiPen in U.S. | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2018/11/28 | 00 : 06 | Business Wire | Teva’s Generic Version of EpiPen® (Epinephrine Injection, USP) Auto-Injector 0.3 mg Now Available in Limited Quantity in ... | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |
| 2018/11/01 | 23 : 19 | Dow Jones News | Teva Shares Rise as Investors Greet Progress in Turnaround | NYSE:TEVA | Teva Pharmaceutical Industries Ltd |